Literature DB >> 18269600

Regional distribution of psoriasis in Italy.

R Saraceno1, R Mannheimer, S Chimenti.   

Abstract

BACKGROUND: Psoriasis is a chronic disease affecting skin and joints; the prevalence varies considerably within ethnic groups and countries.
OBJECTIVE: The aim of this study was to examine the prevalence of psoriasis across Italy and to identify regional differences.
METHODS: The study was conducted in February 2006. A questionnaire was created to survey the prevalence and the geographical distribution of psoriasis in Italy. A representative sample of 3500 families from the contiguous 20 Italian regions was interviewed by a telematic panel.
RESULTS: A total of 4109 individuals were interviewed. The research showed that 2.9% of Italians declared suffering from psoriasis (regional range: 0.8-4.5%); that 52% knew somebody with psoriasis; that 33% knew well the meaning of psoriasis; and that 31% of individuals affected from psoriasis defined the effect on quality of life as high.
CONCLUSION: In association with the socio-cultural data, this is the first study describing the variation in prevalence of psoriasis among Italian regions.

Entities:  

Mesh:

Year:  2008        PMID: 18269600     DOI: 10.1111/j.1468-3083.2007.02423.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  12 in total

Review 1.  Epidemiology of Psoriasis and Psoriatic Arthritis in Italy-a Systematic Review.

Authors:  Francesca Prignano; Veronica Rogai; Elisabetta Cavallucci; Alessandro Bitossi; Volker Hammen; Fabrizio Cantini
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.592

Review 2.  Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies.

Authors:  Louise K Andersen; Mark D P Davis
Journal:  Dermatology       Date:  2016-03-25       Impact factor: 5.366

3.  Alcohol intake and risk of incident psoriasis in US women: a prospective study.

Authors:  Abrar A Qureshi; Patrick L Dominguez; Hyon K Choi; Jiali Han; Gary Curhan
Journal:  Arch Dermatol       Date:  2010-08-16

4.  Depression and the risk of psoriasis in US women.

Authors:  P L Dominguez; J Han; T Li; A Ascherio; A A Qureshi
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-10-03       Impact factor: 6.166

Review 5.  Psoriatic disease and tuberculosis nowadays.

Authors:  Nicola Balato; Luisa Di Costanzo; Fabio Ayala; Anna Balato; Alessandro Sanduzzi; Marialuisa Bocchino
Journal:  Clin Dev Immunol       Date:  2012-05-08

6.  Biological therapy utilization, switching, and cost among patients with psoriasis: retrospective analysis of administrative databases in Southern Italy.

Authors:  Francesca Guerriero; Valentina Orlando; Valeria Marina Monetti; Veronica Russo; Enrica Menditto
Journal:  Clinicoecon Outcomes Res       Date:  2017-12-01

7.  Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative.

Authors:  Giorgio L Colombo; Sergio Di Matteo; Chiara Martinotti; Steffen M Jugl; Praveen Gunda; Mariantonietta Naclerio; Giacomo M Bruno
Journal:  Clinicoecon Outcomes Res       Date:  2018-08-30

8.  Regional variations and prevalence of psoriasis in Germany from 2010 to 2017: a cross-sectional, spatio-epidemiological study on ambulatory claims data.

Authors:  Valerie Andrees; Sandra Wolf; Matthias Augustin; Nicole Mohr; Jobst Augustin
Journal:  BMJ Open       Date:  2021-11-16       Impact factor: 2.692

9.  Moderate and severe plaque psoriasis: cost-of-illness study in Italy.

Authors:  Gl Colombo; Gf Altomare; K Peris; P Martini; G Quarta; M Congedo; A Costanzo; A Di Cesare; E Lapucci; S Chimenti
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

10.  Estimating the Impact of Workplace Bullying: Humanistic and Economic Burden among Workers with Chronic Medical Conditions.

Authors:  A Fattori; L Neri; E Aguglia; A Bellomo; A Bisogno; D Camerino; B Carpiniello; A Cassin; G Costa; P De Fazio; G Di Sciascio; G Favaretto; C Fraticelli; R Giannelli; S Leone; T Maniscalco; C Marchesi; M Mauri; C Mencacci; G Polselli; R Quartesan; F Risso; A Sciaretta; M Vaggi; S Vender; U Viora
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.